Email bookmark
Font : A-A+

Drug information on Osteofos (35 mg) (Alendronate) from Cipla Limited

Osteofos (35 mg)

Cipla Limited
Generic : Alendronate
4 Tablets

Drug Name : Alendronate

Alendronate is used to treat osteoporosis or bone thinning in men and post-menopausal women and Paget's disease or bone deformity. It is also recommended for patients taking steroids that affect bone health.
More Info about Alendronate

Dhanalakshmi Chinnuswamy
Further Checked by The Medindia Medical Review Team on February, 2, 2017
Medindia currently has information on 3080 generic drugs and 110,061 brands that have their prices listed. New drugs with their prices are listed as and when they get approved by the drug controller. Please do write to us ( if a drug is missing from our comprehensive drug price list.

Medical Condition(s) for which Osteofos (35 mg) may be prescribed

Side effects of Osteofos (35 mg)

  Postmenopausal women

  Gastrointestinal: Abdominal pain, nausea, indigestion, constipation, diarrhea, flatulence, acid regurgitation esophageal ulcer, vomiting, difficulty in swallowing and stomach inflammation.

   Musculoskeletal : Bone, muscle/joint pain, muscle cramp and osteonecrosis of the jaw.

  Central Nervous System : Headache and dizziness.

  ENT: Taste perversion.


  Gastrointestinal : Acid regurgitation, flatulence, heart burn, diarrhea, abdominal pain and nausea.

  Body as a Whole : Hypersensitivity reactions, muscle pain, uneasiness, weakness and rarely fever.

  Central Nervous system: Dizziness and fainting.

  Skin: Rash (occasionally with photosensitivity), itching, hair loss, rarely severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.

  Eye: Eye inflammation.

Dosage & When it is to be taken (Indications)

PO: The recommended dose is 5 to 10mg once daily or 35 to 70mg tablet once weekly.

How to use Osteofos (35 mg)?

It comes as a tablet, should be taken on an empty stomach.

When is Osteofos (35 mg) not to be taken? (Contraindications)

Contraindicated in patients with hypersensitivity, decreased level of calcium in blood, esophageal abnormalities and factors which delay esophageal emptying, severe kidney impairment, inability to stand or sit upright for more than half an hour, during pregnancy and breastfeeding.

Warnings and Precautions for Osteofos (35 mg)

Caution needed in patients with history of upper gastrointestinal disorders (discontinue if symptoms worsen); ulcers and active gastrointestinal bleeding.

•Correct vitamin D and calcium deficiency before starting therapy.

•Not recommended for use in patients with CrCl <35 ml/min.

•Proper dental care is important while taking this medication.

•Do not drive a car or operate machinery, avoid alcohol and smoking while taking this medication.

Other Precautions for Osteofos (35 mg)

It may cause severe bone, muscle, or joint pain.

Storage Conditions for Osteofos (35 mg)

Store it at room temperature and in an airtight container. Keep away from children and pets.

Disclaimer : updates the prices regularly, however despite that there may be discrepancies in the prices displayed. This can be due to many reasons including -
  • Difference in GST/local taxes
  • Change in price by the company
  • Updation of information may not have happened at the right time
For the above reasons Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to only provide the initial guidance and it does not intend to replace professional medical opinion in any manner whatsoever.

Buy Medicines (Drug) at Concessional Price from India
Substitutes for Osteofos (35 mg)

View all

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.